NIH-funded research NIH-funded research

Elucidating How Necroptosis Works in Disease

Official title: Elucidating the Molecular Basis of Necroptosis

Funded at University of California Berkeley · NIH-11430555 · Data updated 2026-11-12

Aims to uncover the detailed molecular steps of necroptosis to better understand and eventually treat diseases linked to skin inflammation, gut inflammation, and brain disorders.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of California Berkeley
NIH-funded
Lab location1 site (Berkeley, United States)
Project startAugust 1, 2026
Project endMay 31, 2031
Funding year2026
Award (this year)$329,491
NIH project number1R35GM166219-01
Project IDNIH-11430555 on NIH RePORTER

Who could benefit from this research

Could help

Patients with inflammatory or neurodegenerative diseases where necroptosis is involved may benefit from future therapies arising from this research.

Less likely to help

Healthy individuals or patients without necroptosis-related pathology may not directly benefit.

What this research studies

This project looks at how a specific form of cell death called necroptosis happens at the molecular level, focusing on the ZBP1–RIPK3–MLKL pathway. Researchers will map how the ZBP1 sensor recognizes ligands, how RIPK3 passes signals, and how MLKL forms pores to cause cell death and inflammation. The work uses advanced molecular and cellular techniques to compare human and model organism versions of these proteins to see what is conserved or different. By detailing these steps, scientists hope to identify new targets to prevent harmful cell death in diseases like dermatitis and neurodegenerative conditions.

Why it matters

Potential benefit: Understanding necroptosis could lead to new therapies that reduce inflammation and tissue damage in several diseases.

How similar studies have gone: Previous work has clarified other cell death pathways, and this project advances knowledge specifically on necroptosis with novel mechanistic insights.

Where this research is happening

  • University of California Berkeley
    Berkeley, United States
    Active

Researchers

  • Principal investigator: Xia, Shiyu — University of California Berkeley
  • Study coordinator: Xia, Shiyu

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.